Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Weighted Average) (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $14.9 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 5.65% to $14.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.9 million through Dec 2025, up 5.65% year-over-year, with the annual reading at $14.9 million for FY2025, 5.65% up from the prior year.
- Shares Outstanding (Weighted Average) hit $14.9 million in Q4 2025 for Cumberland Pharmaceuticals, down from $15.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $15.0 million in Q1 2021 to a low of $14.1 million in Q3 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $14.6 million across 5 years, with a median of $14.6 million in 2022.
- Biggest five-year swings in Shares Outstanding (Weighted Average): fell 2.71% in 2022 and later grew 6.45% in 2025.
- Year by year, Shares Outstanding (Weighted Average) stood at $14.9 million in 2021, then fell by 2.29% to $14.6 million in 2022, then dropped by 1.82% to $14.3 million in 2023, then dropped by 1.67% to $14.1 million in 2024, then grew by 5.65% to $14.9 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for CPIX at $14.9 million in Q4 2025, $15.0 million in Q3 2025, and $15.0 million in Q2 2025.